Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01). - Garcia-Donas J; Garrigos L; Lainez N; Santaballa A; Redondo A; Cueva JF; Rubio MJ; Prieto M; Lopez-Guerrero JA; Garcia-Casado Z; Barquin A; Grande E; et al. (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025)